Fred Aslan

Fred Aslan Email and Phone Number

President and Chief Executive Officer at Artiva Biotherapeutics @ Artiva Biotherapeutics
Fred Aslan's Location
San Diego, California, United States, United States
Fred Aslan's Contact Details
About Fred Aslan

Fred Aslan is a President and Chief Executive Officer at Artiva Biotherapeutics at Artiva Biotherapeutics. He possess expertise in corporate development, venture capital, start ups, entrepreneurship, private equity and 10 more skills. He is proficient in English and Portuguese.

Fred Aslan's Current Company Details
Artiva Biotherapeutics

Artiva Biotherapeutics

View
President and Chief Executive Officer at Artiva Biotherapeutics
Fred Aslan Work Experience Details
  • Artiva Biotherapeutics
    President And Chief Executive Officer
    Artiva Biotherapeutics Jan 2021 - Present
    San Diego, California, Us
    Artiva's mission is to deliver to cancer patients highly effective cellular immunotherapies that are safe and immediately accessible. The company is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, for the treatment of hematologic cancers or solid tumors. Artiva was founded on the understanding that NK cells hold enormous therapeutic potential as cancer therapies and the dedication and expertise to overcome technological barriers in the scaling and manufacturing of these cells. Artiva’s platform delivers scalability, quality, and cryopreservation to support a pipeline of safe, effective, versatile, and accessible product candidates.
    View
  • Vyttra Diagnósticos
    Founder, Advisor
    Vyttra Diagnósticos Aug 2013 - Present
    São Paulo, Sp, Br
    Vyttra Diagnosticos has grown to become the largest Brazilian in-vitro diagnostics (IVD) company, selling equipment and reagents to thousands of clinical laboratories across Brazil, with over 200 employees. The Company was formed via a series of acquisitions from 2013 to 2016. Vyttra today has more customers than any other IVD company in Brazil, leading manufacturing facilities, and distribution agreements with dozens of international companies.
    View
  • Baybrazil
    Board Member
    Baybrazil Jul 2011 - Present
    San Francisco Bay Area, Us
    Silicon Valley-based not-for-profit organization with one of largest communities in the US of Brazilian professionals promoting knowledge-exchange and facilitating business between Silicon Valley and Brazil.
    View
  • Vydence Medical
    Founder, Executive Chairman
    Vydence Medical Jan 2011 - Present
    Sao Carlos, Sp, Br
    Vydence Medical has grown to become the largest Brazilian dermatology-focused medical device company with over 150 employees. The Company was initially a distributor of innovative products, such as CoolSculpting from Zeltiq, but after a merger with Industra, the leading Brazilian manufacturer of dermatology-focused medical device products, Vydence became the leading Brazilian company in its segment with the largest market share. The Company’s flagship product is the Etherea MX®, one of the most versatile energy-based platforms in the industry. Vydence is now expanding globally, seeking to become a major player in North America, Europe and Asia. The Company is backed by leading US VCs including Venrock, Aberdare Ventures and Arboretum Ventures.
    View
  • Vividion Therapeutics
    President And Chief Business Officer
    Vividion Therapeutics Sep 2018 - Jan 2021
    San Diego, Ca, Us
    Vividion is a biotech company developing a broad range of small molecule therapies for oncology and other high unmet need indications, mostly by targeting proteins well validated by human genetics but previously considered “undruggable” by conventional approaches. The Company is applying its pioneering synthetic chemistry and chemical proteomics universal screening platform to reveal druggable opportunities across the entire proteome. The Company is backed by leading biotech investors including ARCH, Versant, and Cardinal Partners, and established a foundational partnership with Celgene.
    View
  • Venrock
    Vice President
    Venrock Jun 2006 - Jul 2018
    Invested in biotech, medical devices and diagnostics companies. Was a co-founder and board member of Receptos Pharmaceuticals, a biotech company that listed on NASDAQ in 2013 and was subsequently acquired by Celgene for US$ 7.2 billion. Also led Venrock’s investment in Zeltiq, a medical device company in the dermatology space acquired by Allergan for US$2.4 billion, and PowerVision, a medical device company in the ophthalmology space acquired by Alcon for US$285 million.
  • Atlas Venture
    Intern
    Atlas Venture Jun 2005 - May 2006
    Evaluated biotech and medical device investment opportunities.
  • Curagen Corporation
    Director Business Development
    Curagen Corporation May 2002 - May 2005
    Us
    Responsible for business development, strategic planning, and Head of investor relations for NASDAQ-listed public biotech company developing cancer therapeutics (subsequently acquired by Celldex). Led efforts resulting in $100 million in-licensing deal with TopoTarget A/S for a clinical-stage cancer program. Helped raise $110 million in convertible debt, presented at investor and scientific conferences, and secured sell-side coverage. Helped develop business plan for 454 Life Sciences (CuraGen subsidiary) partnership with Roche (454 Life Sciences acquired by Roche in 2007 for $150 million).
    View
  • The Boston Consulting Group
    Associate
    The Boston Consulting Group Sep 2000 - May 2002
    Boston, Massachusetts, Us
    Advised top biotech, pharmaceutical and medical device companies on strategic and operational issues. Led client teams and conducted quantitative and qualitative data analysis, market research and competitive analysis. Projects ranged from corporate strategy and commercial assessment to post merger integration and resource realignment. Clients included Amgen, Biogen, Bristol Myers Squib and Roche.
    View

Fred Aslan Skills

Corporate Development Venture Capital Start Ups Entrepreneurship Private Equity Strategy Due Diligence Financial Modeling Strategic Partnerships Valuation Investments Product Management Capital Investor Relations Mergers

Fred Aslan Education Details

  • Harvard Business School
    Harvard Business School
    Master Of Business Administration (Mba)
  • Yale University
    Yale University
    Doctor Of Medicine (Md)
  • Duke University
    Duke University
    General

Frequently Asked Questions about Fred Aslan

What company does Fred Aslan work for?

Fred Aslan works for Artiva Biotherapeutics

What is Fred Aslan's role at the current company?

Fred Aslan's current role is President and Chief Executive Officer at Artiva Biotherapeutics.

What is Fred Aslan's email address?

Fred Aslan's email address is fa****@****hbs.edu

What is Fred Aslan's direct phone number?

Fred Aslan's direct phone number is +165056*****

What schools did Fred Aslan attend?

Fred Aslan attended Harvard Business School, Yale University, Duke University.

What skills is Fred Aslan known for?

Fred Aslan has skills like Corporate Development, Venture Capital, Start Ups, Entrepreneurship, Private Equity, Strategy, Due Diligence, Financial Modeling, Strategic Partnerships, Valuation, Investments, Product Management.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.